Literature DB >> 29141964

Acute decompensated pulmonary hypertension.

Laurent Savale1,2,3, Jason Weatherald4, Xavier Jaïs5,2,3, Constance Vuillard2, Athénaïs Boucly5,2,3, Mitja Jevnikar5,2,3, David Montani5,2,3, Olaf Mercier3,6, Gerald Simonneau5,2,3, Elie Fadel3,6, Olivier Sitbon5,2,3, Marc Humbert5,2,3.   

Abstract

Acute right heart failure in chronic precapillary pulmonary hypertension is characterised by a rapidly progressive syndrome with systemic congestion resulting from impaired right ventricular filling and/or reduced right ventricular flow output. This clinical picture results from an imbalance between the afterload imposed on the right ventricle and its adaptation capacity. Acute decompensated pulmonary hypertension is associated with a very poor prognosis in the short term. Despite its major impact on survival, its optimal management remains very challenging for specialised centres, without specific recommendations. Identification of trigger factors, optimisation of fluid volume and pharmacological support to improve right ventricular function and perfusion pressure are the main therapeutic areas to consider in order to improve clinical condition. At the same time, specific management of pulmonary hypertension according to the aetiology is mandatory to reduce right ventricular afterload. Over the past decade, the development of extracorporeal life support in refractory right heart failure combined with urgent transplantation has probably contributed to a significant improvement in survival for selected patients. However, there remains a considerable need for further research in this field.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29141964     DOI: 10.1183/16000617.0092-2017

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  10 in total

Review 1.  Advanced airway management and respiratory care in decompensated pulmonary hypertension.

Authors:  Cyrus A Vahdatpour; John J Ryan; Joshua M Zimmerman; Samuel J MacCormick; Harold I Palevsky; Hassan Alnuaimat; Ali Ataya
Journal:  Heart Fail Rev       Date:  2021-09-02       Impact factor: 4.654

2.  Percutaneous dual-outflow extracorporeal membrane oxygenation support in secondary right ventricular failure.

Authors:  Florian Hecker; Harald Keller; Mariuca Vasa-Nicotera; Sonja Iken; Tomas Holubec
Journal:  JTCVS Tech       Date:  2022-02-21

3.  Management of acutely decompensated chronic thromboembolic pulmonary hypertension in late pregnancy: a case report.

Authors:  Luca Valko; Gyorgyi Csosza; Akos Merei; Diana Muhl; Reka Faludi; Kristof Karlocai; Andras Lorx; Janos Gal
Journal:  BMC Pregnancy Childbirth       Date:  2019-10-21       Impact factor: 3.007

4.  Pulmonary Tumor Embolism: A Rare Cause of Acute Pulmonary Hypertension.

Authors:  Timothy Chong; Joseph Park; Hafiz M Aslam; Shahryar Ansari; Sara L Wallach
Journal:  Cureus       Date:  2020-12-03

5.  A Case of Complex Pulmonary Hypertension: the Importance of Diagnostic Investigation.

Authors:  Aninka Saboe; Vani Marindani; Charlotte Johanna Cool; Hilman Syawaluddin; Hussein S Kartamihardja; Prayudi Santoso; Mohammad Rizki Akbar
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2022-01-08

6.  External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension.

Authors:  Marcos V F Garcia; Rogerio Souza; Pedro Caruso
Journal:  ERJ Open Res       Date:  2022-03-07

7.  Effect of Levosimendan on Acute Decompensated Right Heart Failure in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Authors:  Chao Qu; Wei Feng; Qi Zhao; Qi Liu; Xing Luo; Gang Wang; Meng Sun; Zhibo Yao; Yufei Sun; Shenglong Hou; Chunyang Zhao; Ruoxi Zhang; Xiufen Qu
Journal:  Front Med (Lausanne)       Date:  2022-03-04

8.  Exploring the failing right ventricle in pulmonary hypertension by cardiac magnetic resonance: An in vivo study utilizing Macitentan.

Authors:  Gerard Murphy; Geeshath Jayasekera; James Mullin; Lindsay Gallagher; David J Welsh
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

9.  Renal Replacement Therapy in Patients With Acute Decompensated Pulmonary Hypertension Admitted to the Intensive Care Unit.

Authors:  Marcos Garcia; Rogerio Souza; Pedro Caruso
Journal:  Cureus       Date:  2022-09-05

10.  Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.

Authors:  Malik Bisserier; Prabhu Mathiyalagan; Shihong Zhang; Firas Elmastour; Peter Dorfmüller; Marc Humbert; Gregory David; Sima Tarzami; Thomas Weber; Frederic Perros; Yassine Sassi; Susmita Sahoo; Lahouaria Hadri
Journal:  Circulation       Date:  2021-06-03       Impact factor: 39.918

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.